Matthew Bernard Carroll, MD
Department of Rheumatology
Chief Consultant to Air Force Surgeon General
81st Medical Group
Keesler Medical Center
Keesler AFB, MS, USA
Dr. Carroll is a practicing Rheumatologist and Internist who also serves as the Designated Institutional Official of Keesler Medical Center, Keesler Air Force Base, Mississippi. He has served as the Institutional Review Board Chairperson for Keesler Medical Center since 2010. Dr. Carroll’s research covers a broad spectrum of interests ranging from HCV seroprevalence amongst military retirees, genetics of allopurinol/febuxostat dosing, and the role of biologic response modifiers in the treatment of conditions such as subacromial bursitis and erosive osteoarthritis. Previous research has focused on the reactivation of Hepatitis B in patients receiving tumor necrosis factor inhibitors. He has authored or co-authored 15 peer-reviewed articles and has articles awaiting publication. He has participated in the development of joint Department of Defense/Veteran’s Affairs clinical practice guidelines for Chronic Multisystem Illness.
His research interests include: Role of Interleukin-1 blockade in erosive osteoarthritis, bursitis, hemochromatosis arthropathy, gout, and pseudogout, HCV seroprevalence in military retired population, Genetic of Gout (SNPs of Xanthine Oxidase and HPRT1) and how they relate to Gout, Hyperuricemia, and therapy and Effect of biologic response modifiers and in particular Tumor Necrosis Factor alpha inhibitors on reactivation of Hepatitis B virus.
AWARDS AND HONORS
• Distinguished Graduate, USAF Academy, CO (1992)
• Resident Teacher of the Year, David Grant Medical Center, CA (1998)
• Society of Air Force Physicians Arthur Grollman Award for Outstanding Resident’s Presentation (1999)
• Society of Air Force Physicians Major General Archie Hoffman Award For Excellence in Clinical Medicine (2002)
• Subspecialist Teacher of the Year, Internal Medicine Department, Keesler Medical Center, Keesler AFB, MS (2008)
• American College of Physicians (ACP) (1996- Present)
• American College of Rheumatology (2005-Present)
1. Carroll MB, Higgs JB. Synovial Hemangioma presenting as recurrent monarthritis. Arch Dis Child. 2007; 92(7): 623-624. doi: 10.1136/adc.2006.114066
2. Carroll MB. MELAS Masquerading as Systemic Vasculitis. J Clin Rheumatol. 2007; 13(6): 334-337. doi: 10.1097/RHU.0b013e31815c2516
3. Carroll MB, Bond MI. Use of TNF-α Inhibitors in patients with Chronic Hepatitis B. Semin Arthritis Rheum. 2008; 38(3): 208-217. doi: 10.1016/j.semarthrit.2007.10.011
4. Carroll MB, Holmes R. Safety of anti-tumor necrosis factor (anti-TNF) therapy in patients with Chronic Hepatitis B. Hepatitis B Annual. 2009.
5. Carroll MB, Forgione M. Achromobacter xylosoxidans presenting as a suprapatellar bursitis. J Clin Rheumatol. 2010; 16(1): 45-46.
6. Carroll MB, Forgione M. Use of tumor necrosis factor alpha inhibitors in hepatitis B surface antigen-Positive patients: a literature review and potential mechanisms of action. Clin Rheumatol. 2010; 29(9): 1021-1029.
7. Carroll MB. The impact of biologic response modifiers on hepatitis B virus infection. Expert Opin Biol Ther. 2011; 11(4): 533-544. doi: 10.1517/14712598.2011.554810
8. Carroll MB. Sternocostoclavicular Hyperostosis: A Review. Ther Adv Musculoskel Dis. 2011; 3(2): 101-110.
9. Carroll MB, Holmes R. Dermatomyositis and HIV Infection: case report and review of the literature. Rheumatol Int. 2011; 31(5): 634-638.
10. Carroll MB, DeCastro M, Hust N, et al. The Relationship of two Xanthine Oxidase Single Nucleotide Polymorphisms to Hyperuricemia, Gout, and Dose of Xanthine Oxidase Inhibitor. J Musculoskel Res. 2013; 16(1). doi: 10.1142/S0218957713500048
11. Smith B, Carroll MB. Persistent Lymphadenopathy Due to IgG4 Related Disease. Case Reports in Immunology. 2012; 158208: 4. doi: 10.1155/2012/158208
12. Rezayat T, Carroll MB, Ramsey CB, Smith A. A Case of Relapsing Kikuchi Fujimoto Disease. Case Reports in Otolaryngology. 2013; 364795: 4. doi: 10.1155/2013/364795
13. Laufer CB, Carroll MB. Hepatitis C Virus, Sarcoidosis, and Polyarteritis Nodosa: Striking a Balance between the Immune System, Disease, and Therapy. 3rd World Congress on Controversies, Debates, and Consensus in Bone, Muscle, and Joint Diseases. 2015; 83.
14. Carroll MB, Motley SA, Wohlford S, Ramsey CB. Rilonacept in the treatment of subacromial bursitis: A randomized, non-inferiority, unblinded study versus triamcinolone acetonide. Joint Bone Spine. 2015.
15. Laufer CB, Carroll MB. Hepatitis C Virus in the US Military Retiree Population: To Screen, or Not to Screen? J Clin Med Res. 2015; 7(10): 757-761. doi: 10.14740/jocmr2233w
16. Carroll MB. Canakinumab in the Treatment of Erosive Hand Osteoarthritis: A Case Series. J Case Rep Stud. 2015; 3(5): 508-510.
17. Carroll MB, Tessier CM. Prevalence of Vitamin B12 Deficiency and Anti-Gastric Parietal Cell Antibodies in Patients with Rheumatoid Arthritis. J Musculoskelet Disord Treat. 2015; 1: 003.